Certainly seems to be a slight change in rhetoric unless I also missed something. Honestly, I think looking for a partnership with a buyout further down the line doesn't seem to be a crazy call, given all the potential non-cancer FTO-related avenues that could be explored.
We can't turn over every leaf and fully maximise value if we are aiming for a transaction in the shorter term. Not to mention whatever else the RAC team are cooking - I'm sure there will be something as always!
RAC media coverage, page-712
-
- There are more pages in this discussion • 1,577 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
